Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.06 | 8.37 |
| PEG Ratio (TTM) | -0.02 | -9.01 |
| P/S Ratio (TTM) | 0.57 | 0.50 |
| P/B Ratio (TTM) | 0.03 | 1.39 |
| P/FCF Ratio (TTM) | -0.06 | 13.82 |
| Price to 5YR AVG Earnings Ratio | N/A | 13.21 |
| Price to 5YR AVG FCF Ratio | N/A | 61.15 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -24.75% | 4.44% |
| ROE (TTM) | -51.91% | 4.00% |
| Net Profit Margin (TTM) | -834.78% | 0.92% |
| ROIC 5YR AVG | N/A | 11.54% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -44.91% | N/A | N/A |
| Revenue | 212.55% | N/A | N/A |
| Net Income | -50.60% | N/A | N/A |
| Cash Flow | -18.69% | N/A | N/A |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.25 | 1.95 |
| Quick Ratio (TTM) | 1.09 | 1.15 |
| D/E Ratio (TTM) | 1.08 | 0.54 |
| Interest Coverage (TTM) | -3.17 | 5.33 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | N/A | 3.73 |
| LTL to 5YR AVG FCF | N/A | 16.28 |
| Shares Outstanding Growth 5YR AVG | N/A | -7.27% |